Sudden unexpected death related to enterovirus myocarditis: histopathology, immunohistochemistry and molecular
Imed Gaaloul1, Samira Riabi, Rafik Harrath
1Laboratory of Transmissible Diseases LR99-ES27, Faculty of Pharmacy, Avenue Avicenne, 5000, Monastir, Tunisia. chbeli_imed@yahoo.fr
Insights
Viral myocarditis, often caused by coxsackie B enterovirus, is a significant factor in sudden unexpected deaths. This study found a higher prevalence of viral myocarditis in victims compared to controls.
Area of Science:
- Cardiology
- Virology
- Pathology
Background:
- Viral myocarditis is a leading cause of sudden unexpected death in young individuals.
- Coxsackievirus B3 (CVB3) has been historically linked to myocarditis.
- Current diagnostic methods for myocarditis lack sensitivity, necessitating advanced approaches.
Purpose of the Study:
- To investigate the prevalence of viral myocarditis in sudden unexpected death cases.
- To identify the role of enteroviruses, specifically coxsackie B enterovirus, in myocarditis pathogenesis.
- To compare findings in sudden unexpected death victims with control subjects.
Main Methods:
- Post-mortem analysis of sudden unexpected death victims and controls.
- Immunohistochemical detection of enteroviral capsid protein VP1.
- Molecular pathology for enteroviral genome detection using RT-PCR.
- Analysis of myocardial inflammatory reactions, including T and B lymphocytes.
Main Results:
- Enterovirus was detected in 12.5% of sudden unexpected death cases, with none in controls.
- Enteroviral capsid protein VP1 was identified in enterovirus-positive cases.
- Sudden unexpected death victims showed a significant presence of T and B lymphocytes compared to controls.
Conclusions:
- Viral myocarditis is more prevalent in sudden unexpected death cases than in controls.
- Coxsackie B enterovirus likely plays a significant role in the pathogenesis of myocarditis.
- Advanced diagnostic techniques enhance the understanding of myocarditis etiology.
Background:
Viral myocarditis is a major cause of sudden unexpected death in children and young adults. Until recently, coxsackievirus B3 (CVB3) has been the most commonly implicated virus in myocarditis. At present, no standard diagnosis is generally accepted due to the insensitivity of traditional diagnostic tests. This has prompted health professionals to seek new diagnostic approaches, which resulted in the emergence of new molecular pathological tests and a more detailed immunohistochemical and histopathological analysis. When supplemented with immunohistochemistry and molecular pathology, conventional histopathology may provide important clues regarding myocarditis underlying etiology.
Methods:
This study is based on post-mortem samples from sudden unexpected death victims and controls who were investigated prospectively. Immunohistochemical investigations for the detection of the enteroviral capsid protein VP1 and the characterization and quantification of myocardial inflammatory reactions as well as molecular pathological methods for enteroviral genome detection were performed.
Results:
Overall, 48 sudden unexpected death victims were enrolled. As for controls, 37 cases of unnatural traffic accident victims were studied. Enterovirus was detected in 6 sudden unexpected death cases (12.5 %). The control samples were completely enterovirus negative. Furthermore, the enteroviral capsid protein VP1 in the myocardium was detected in enterovirus-positive cases revealed by means of reverse transcriptase-polymerase chain reaction (RT-PCR). Unlike control samples, immunohistochemical investigations showed a significant presence of T and B lymphocytes in sudden unexpected death victims.
Conclusions:
Our findings demonstrate clearly a higher prevalence of viral myocarditis in cases of sudden unexpected death compared to control subjects, suggesting that coxsackie B enterovirus may contribute to myocarditis pathogenesis significantly.
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis I: Introduction
Myocarditis III: Medical Management
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification

